Log in

OTCMKTS:PUREPure Bioscience Stock Price, Forecast & News

+0.19 (+18.27 %)
(As of 05/29/2020 04:00 PM ET)
Today's Range
Now: $1.23
50-Day Range
MA: $0.73
52-Week Range
Now: $1.23
Volume504,429 shs
Average Volume141,113 shs
Market Capitalization$106.88 million
P/E RatioN/A
Dividend YieldN/A
PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. It manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection and formulates with other compounds. The company offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control, a food contact processing aid for fresh produce and raw poultry; PURE Multi-Purpose and Floor Cleaner Concentrate used to clean various resilient surfaces, including floors, glass, and food contact surfaces; and PURE Multi-Purpose Hi-Foam Cleaner Concentrate used to clean stainless steel equipment, resilient floors, walls, and painted surfaces. Its SDC-based disinfecting and sanitizing products comprising Axen30, a hard surface disinfectant; Axenohl, an antimicrobial formulation used as a raw material ingredient in the manufacturing of consumer and commercial disinfecting and sanitizing products; and SILVÉRION, an antimicrobial solution used against bacteria, viruses, yeast, and molds. It sells its products to distributors and end users. PURE Bioscience, Inc. was founded in 1992 and is headquartered in El Cajon, California.
Read More
Pure Bioscience logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.70 out of 5 stars

Industry, Sector and Symbol

Industry Miscellaneous chemical products
Current SymbolOTCMKTS:PURE



Sales & Book Value

Annual Sales$1.91 million
Book Value$0.02 per share


Net Income$-6,550,000.00
Net Margins-268.12%


Market Cap$106.88 million
Next Earnings Date6/11/2020 (Estimated)
OptionableNot Optionable

Receive PURE News and Ratings via Email

Sign-up to receive the latest news and ratings for PURE and its competitors with MarketBeat's FREE daily newsletter.

Pure Bioscience (OTCMKTS:PURE) Frequently Asked Questions

How has Pure Bioscience's stock been impacted by COVID-19 (Coronavirus)?

Pure Bioscience's stock was trading at $0.5389 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, PURE shares have increased by 128.2% and is now trading at $1.23. View which stocks have been most impacted by Coronavirus.

When is Pure Bioscience's next earnings date?

Pure Bioscience is scheduled to release its next quarterly earnings announcement on Thursday, June 11th 2020. View our earnings forecast for Pure Bioscience.

How were Pure Bioscience's earnings last quarter?

Pure Bioscience, Inc. (OTCMKTS:PURE) posted its quarterly earnings data on Thursday, March, 12th. The company reported ($0.01) EPS for the quarter. The company earned $0.35 million during the quarter. Pure Bioscience had a negative return on equity of 398.58% and a negative net margin of 268.12%. View Pure Bioscience's earnings history.

Has Pure Bioscience been receiving favorable news coverage?

News coverage about PURE stock has been trending neutral on Saturday, InfoTrie Sentiment reports. The research group identifies positive and negative news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Pure Bioscience earned a coverage optimism score of 0.5 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near term. View the latest news aboutPure Bioscience.

Who are some of Pure Bioscience's key competitors?

What other stocks do shareholders of Pure Bioscience own?

Who are Pure Bioscience's key executives?

Pure Bioscience's management team includes the following people:
  • Mr. Henry R. Lambert, CEO, Sec. & Director (Age 68)
  • Mr. Mark Stuart Elliott, VP of Fin. (Age 44)
  • Mr. Thomas Richard Myers, Chief Operating Officer (Age 67)
  • Ms. Bridget C. Tinsley-Cormier M.S., Sr. VP of Technology & Bus. Devel. and VP of Market Devel.

What is Pure Bioscience's stock symbol?

Pure Bioscience trades on the OTCMKTS under the ticker symbol "PURE."

How do I buy shares of Pure Bioscience?

Shares of PURE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Pure Bioscience's stock price today?

One share of PURE stock can currently be purchased for approximately $1.23.

How big of a company is Pure Bioscience?

Pure Bioscience has a market capitalization of $106.88 million and generates $1.91 million in revenue each year. Pure Bioscience employs 9 workers across the globe.

What is Pure Bioscience's official website?

The official website for Pure Bioscience is www.purebio.com.

How can I contact Pure Bioscience?

Pure Bioscience's mailing address is 9669 HERMOSA AVENUE, RANCHO CUCAMONGA CA, 91730. The company can be reached via phone at 619-596-8600 or via email at [email protected]

This page was last updated on 5/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.